Stonegate Investment Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,237
Closed -$587K 457
2025
Q2
$587K Buy
2,237
+119
+6% +$29K 0.01% 226
2025
Q1
$493K Sell
2,118
-452
-18% -$110K 0.01% 218
2024
Q4
$589K Buy
2,570
+62
+2% +$14.2K 0.02% 200
2024
Q3
$560K Buy
2,508
+178
+8% +$39.1K 0.01% 217
2024
Q2
$474K Buy
2,330
+615
+36% +$125K 0.01% 231
2024
Q1
$375K Buy
1,715
+314
+22% +$69.2K 0.01% 247
2023
Q4
$318K Buy
1,401
+38
+3% +$7.98K 0.01% 244
2023
Q3
$274K Sell
1,363
-194
-12% -$40.9K 0.01% 253
2023
Q2
$323K Buy
1,557
+430
+38% +$83.4K 0.01% 242
2023
Q1
$222K Buy
+1,127
New +$232K 0.01% 287

Other funds holding LH

Stonegate Investment Group's LH Position: Q3 2025 in Review

Stonegate Investment Group sold out of Labcorp (LH) in Q3 2025, closing a stake of 2,237 shares — an estimated $587K sold.

Stonegate Investment Group first reported a position in LH in Q1 2023 and held it in 10 quarters. The position peaked at $589K in Q4 2024. 1,008 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Stonegate Investment Group reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Stonegate Investment Group sold 2,237 Labcorp shares in Q3 2025, an estimated $587K.
  • Stonegate Investment Group first reported a position in Labcorp in Q1 2023 and held it in 10 quarters.
  • Stonegate Investment Group's Labcorp position peaked at $589K in Q4 2024.
  • 1,008 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.